PM
DGX icon

Parametrica Management’s Quest Diagnostics DGX Stock Holding History

Parametrica Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,627
Closed -$302K – 214
2018
Q4 		$302K Buy
+3,627
New +$340K 0.37% 118
2017
Q4 		– Sell
-2,201
Closed -$206K – 379
2017
Q3 		$206K Buy
+2,201
New +$234K 0.09% 318

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parametrica Management's DGX Position: Q1 2019 in Review

Parametrica Management sold out of Quest Diagnostics (DGX) in Q1 2019, closing a stake of 3,627 shares — an estimated $302K sold.

Parametrica Management first reported a position in DGX in Q3 2017 and held it in 2 quarters. The position peaked at $302K in Q4 2018. 656 funds tracked by Wall St. Rank hold DGX as of Q1 2019.

  • Parametrica Management reported no remaining Quest Diagnostics position as of Q1 2019 after selling out during the quarter.
  • Parametrica Management sold 3,627 Quest Diagnostics shares in Q1 2019, an estimated $302K.
  • Parametrica Management first reported a position in Quest Diagnostics in Q3 2017 and held it in 2 quarters.
  • Parametrica Management's Quest Diagnostics position peaked at $302K in Q4 2018.
  • 656 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2019.

Based on Parametrica Management's 13F filing for Q1 2019, filed 7 May 2019.